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Abstract
Background: The normal process of aging causes numerous physiological changes that affect
pharmacodynamics and pharmacokinetics. Therefore, the geriatric population is more vulnerable
to the effects of potentially inappropriate medication. The American Geriatric Society’s Beers
Criteria identifies potentially inappropriate medication to be avoided for this population and can
be implemented in efforts to avoid risks associated for this population.
Aim and Methods: The purpose of this quality improvement project was to implement the Beers
Criteria to identify potentially inappropriate medications among patients 65 years and older. The
objectives were to increase the percentage of charts reviewed for inappropriate medications and
to increase the use of alternative treatments based on Beers Criteria recommendations.
Results: During the medication reconciliation process, the Beers Criteria was implemented to
assess for inappropriate medications for eligible patients. A checklist was utilized to document
the intervention process and the physician’s decision to continue or alter treatment. On a weekly
basis, the student determined the percentage of charts reviewed and the percentage of altered
treatment. Of the 112 geriatric patients included, 103 (91.3%) patients had their medications
reviewed and 59 (57.2%) patients had at least one potentially inappropriate medication
identified. However, only 7 (11.8%) patients had the medication altered.
Implications for Practice: The implementation of the Beers Criteria will assist healthcare
providers in identifying potentially inappropriate medications, preventing use of these
medications, and utilizing alternative treatment to promote medication safety and optimize
patient outcomes in geriatric patients.
Keywords: Beers Criteria, geriatric, elderly, medication safety, polypharmacy,
potentially inappropriate medication

BEERS CRITERIA IMPLEMENTATION
Identification of Potentially Inappropriate Medication Utilizing the
Beers Criteria Among Elderly Patients
The prescription of inappropriate medication (PIM) is the use of medicines and herbal
supplements in which the risk of an adverse drug event (ADE) outweighs its benefit when there
are safer and/or more effective alternative medication or treatment options available. PIM also
includes the use of medications that may increase the likelihood of drug-drug interactions, drugdisease interactions, misuse, overuse, and underuse of clinically indicated medications (Boland,
Guignard, Dalleur, & Lang, 2016). Unfortunately, this is a common issue among the geriatric
population 65 years and older due to the many factors that contribute to their vulnerability to
PIMs. These contributing factors include age-related changes that alter pharmacokinetics and
pharmodynamics; multiple chronic conditions (MCC); polypharmacy; physical and cognitive
impairment; lack of adherence to complex medication regimens; and the lack of awareness and
skills of healthcare providers regarding pharmacology in the geriatric population (Boland et al.,
2016).
The American Geriatric Society’s (AGS) Beers Criteria for Potentially Inappropriate
Medication Use in Older Adults is one of the leading sources of evidence-based information
regarding the safety of prescription medication for elderly patients. The Beers Criteria identifies
medications and classes of medications that are considered “potentially inappropriate” for use in
the elderly population (Health in Aging, 2015). Therefore, healthcare providers should avoid
these listed medications that present a higher risk of ADEs and consider a safer alternative
medication or non-drug remedy for patients 65 years and older. By utilizing this criterion,
healthcare providers can help prevent ADEs and other drug-related complications in the elderly
population. However, the lack of awareness and implementation of the Beers Criteria prevents
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healthcare providers from identifying PIMs and considering other alternative treatment options.
As a result, the use of PIMs continues to be an issue among the geriatric population 65 years and
older.
Statement of the Problem
The normal process of aging lends to numerous physiological changes; therefore, the
effects of medication experienced by an older adult are unpredictable. Pharmacodynamics, or the
study of the effects of drugs on the human body, is often difficult to predict and may result in an
alteration in the desired effects of a drug because receptor sites may lose affinity or its decrease
in responsiveness to medication occurring with age (Terrery & Nicoteri, 2016). Similarly, the
aging process also alters pharmacokinetics, the study of the human body’s involvement and its
effect on drug absorption, distribution, metabolism, and elimination (Terrery & Nicoteri, 2016).
There are several physiological changes that occur in older adults that may affect
pharmacokinetics including increased body fat, decreased body mass, decreased serum albumin,
decreased liver size, slow cytochrome P450 reactions, inadequate renal function, and decreased
cardiac output (Terrery & Nicoteri, 2016).
In addition to these physiological changes, the prevalence of MCC increases with age and
is prevalent among the geriatric population (U.S. Department of Health and Human Services,
2010). Therefore, certain chronic conditions or disease states such as chronic kidney disease
(CKD) may also affect pharmacodynamics and pharmacokinetics. Management of these chronic
conditions may require a complex medication regimen resulting in polypharmacy, a common
phenomenon in the aged population that is associated with PIM use and ADEs (Zeenny, Wakim,
& Kuyumjian, 2017). Due to the geriatric population’s increased risk and vulnerability to PIMs,
the Beers Criteria was designed for the identification of PIMs and prevention of ADEs in this
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population. The problem occurs when healthcare providers fail to utilize and implement the
Beers Criteria into practice resulting in the continued use of PIMs for this vulnerable population.
Background and Significance
The rapid aging and current increase in the number and proportion of the older adult
population is an unprecedented event in United States’ history. It is predicted that the American
geriatric population aged 65 or older will more than double, numbering approximately 89 million
people by 2050 (Centers for Disease Control and Prevention [CDC], 2013; Ortman, Velkoff, &
Hogan, 2014). Despite the public health strategies and advances in medical treatment that have
increased the life expectancy of older adult by 30 years, the risk of developing a chronic disease
increases as an individual ages (CDC, 2013). The root causes of these diseases are associated
with unhealthy behaviors from an early age and the natural physiological changes that occur with
the aging process (CDC, 2013). According to the CDC (2013), more than a quarter of all
Americans or two out of every three older Americans have been diagnosed with MCC. The
burden of MCC often results in a gradual decline in activities of daily living, diminished quality
of life, and increased health care costs (CDC, 2013). It is estimated, that the geriatric population
accounts for approximately 66% of the health care budget and 95% of all health care costs for
older adults are used to treat MCC (CDC, 2013).
Although heart disease and cancer pose the greatest risk for the older adult, CKD is
another chronic condition that the older adult is at risk for developing as one ages. CKD is
defined as an abnormality in renal structure or function that results in a glomerular filtration rate
(GFR) of less than 60 ml/min/1.73m2 for a duration of at least three months or longer (National
Kidney Foundation, 2014). Common risk factors for developing CKD include hypertension,
diabetes mellitus, hyperlipidemia, and elevated uric acid; therefore, adults with diabetes mellitus
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and/or hypertension are at higher risk for developing CKD than those without these conditions
(CDC, 2017). According to the CDC (2017), it is estimated that 30 million people or 15% of
adults suffer from CKD. Specifically, in the United States, it is estimated that approximately
661,000 individuals have been diagnosed with CKD (National Institute of Diabetes and
Digestive and Kidney Diseases, 2016). Not only can CKD lead to other health complications, but
also the lack of renal function results in ineffective metabolism and elimination of medication.
Therefore, the geriatric population with CKD is at higher risk of medication overdose, toxicity,
and ADEs.
As the prevalence of MCC increases with age, the geriatric population has a high
likelihood of being administered and/or consuming a wide variety of medications to manage
their conditions. Based on a survey taken in 2002, approximately 25% of the overall United
States population takes at least five or more medications per week (Rambhade, Chakarborty,
Shrivastava, Patil, & Rambhade, 2012). For the geriatric population 65 years and older, this
percentage significantly increases to approximately 50% consuming five or more medications
and 12% taking 10 or more prescriptions per week (Rambhade et al., 2012). Hence,
polypharmacy is a substantial concern among this population and is associated with increased
drug costs, poor adherence to medication regimens, ADEs, and hospitalization (Terrery &
Nicoteri, 2016; Rambhade et al., 2012). Across the United States, polypharmacy and its ADEs
were responsible for approximately 100,000 emergency hospitalizations in the elderly population
65 years and older between the years 2007 to 2009 (Terrery & Nicoteri, 2016). Approximately
$136 billion of medical costs are expended on the treatment of the over 2 million ADRs that
occur each year (Terrery & Nicoteri, 2016).
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As one of the leading sources of information regarding medication safety for the geriatric
population, the AGS’ Beers Criteria for Potentially Inappropriate Medication Use in Older
Adults identifies medications that are considered “potentially inappropriate” and should be
avoided if alternative treatment options such a safer medication, lifestyle changes, or nonmedication therapy are available for use in the elderly population (Health in Aging, 2015). These
PIMs pose a greater risk than the benefits for the older patient 65 years and older. The Beers
Criteria is regularly updated as new research is published regarding new medication and the
safety of already existing treatment methods (Health in Aging, 2015). Utilizing a time-testing
method for treatment guideline development and following the Institute of Medicine, the Beers
Criteria was last updated in 2015 after 6,700 high-quality research studies regarding certain PIMs
prescribed for older adults were reviewed by the AGS’ expert panel (Health in Aging, 2015).
Although it may be utilized to identify PIMS and prevent ADEs in the elderly population, the
Beers Criteria is a reference tool and should not replace the healthcare provider’s clinical
judgment since it does not take into consideration the patient’s unique circumstances.
Assessment
This quality improvement project was implemented at a nephrology specialty practice
clinic. This practice is currently being operated by a physician and three support staff including
an office manager, a medical assistant, and a front desk receptionist. Medicare and Medicaid are
accepted, as well as all other commercial and private insurances. The clinic refers and
collaborates with primary care and other various specialty practices in order to provide
comprehensive disease management and care plans for patients aged 65 years and older with
MCC.
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Stakeholder Engagement
A stakeholder may be defined as an individual or a group of individuals with an interest
in clinical decisions and improvements related to the evidence supporting these changes (Agency
for Healthcare Research and Quality, 2014). At this specialty clinic, the main stakeholders would
consist of the patients and their families, the health care provider and support staff, and payers
such as employers and insurance companies. The patients’ interests in the clinic as a stakeholder
stems from concerns in relation to the severity of their conditions, most effective treatments, and
feasible treatment options in regards to cost, ease of implementation, and maintenance (Agency
for Healthcare Research and Quality, 2014). Healthcare providers are the decision-makers who
identify gaps in the literature and utilize the existing research regarding evidence-based practices
to implement safe and effective treatment options while avoiding harmful interventions (Agency
for Healthcare Research and Quality, 2014). In order to implement best practice and make safe
treatment recommendations, a healthcare provider must maintain an appropriate knowledge-base
and stay current with recent evidence-based guidelines for quality patient care (Agency for
Healthcare Research and Quality, 2014). Payers attempt to ensure that patients are provided
quality and evidence-based treatment to expedite healing, optimize normal function, and prevent
complications that increase direct and indirect medical costs (Agency for Healthcare Research
and Quality, 2014). Therefore, each and every stakeholder is involved and has a vested interest in
the use of evidence-based practices, quality improvement, and successful implementation of
effective medical treatment.
Assessment of the Organization
There are approximately 1,500 patients attending and being seen at this clinic. On
average, the physician will see approximately 10 patients per day in the afternoon. Only patients
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of adult age of 18 years and older are seen. The majority of patients are older adults between the
ages of 62-83 years. Approximately 40% of the patients seen at this clinic are females, and the
other 60% are males. The majority of the patients are either African-American or Hispanic.
Approximately 48% of the patients are African-American, 36% are Latino/Hispanic, and 16%
are Caucasian (non-Hispanic). Common chronic conditions and diagnoses seen at this clinic
include CKD, diabetes mellitus type 2, hypertension, hyperlipidemia, gastroesophageal reflux
disease, hypothyroidism, and coronary artery disease. An estimated 80% of the patients seen at
this practice have CKD. Approximately, 60% of the geriatric population 65 years and older are
diagnosed with CKD with an estimated 55% of these patients with CKD stage 3 and another
10% are stage 4.
Due to the age and comorbidities of the patients seen at this clinic, polypharmacy is
common. Based on a randomized review of 30 patient charts, approximately 28% of patients are
taking 3-4 prescription medications and another 60% are taking 5 or more. This is in line with
the national statistics (Rambhade et al., 2012). Common prescription drugs documented in the
patients’ charts include tramadol, levothyroxine, allopurinol, amitriptyline, aspirin, diuretics,
vasodilators, antihypertensive medication, and anti-diabetic medication.
In addition to polypharmacy, PIMs were identified utilizing the AGS’ Beers Criteria. The
chart review revealed approximately 53% of patients seen at this clinic take at least one PIM and
another 17% take two or more PIMs. Identified PIMs include amitriptyline, hydralazine,
minoxidil, doxazosin, terazosin, clonidine, and diphenhydramine. Besides prescription
medications, some patients also consume vitamins, electrolytes, and other supplements such as
sodium bicarbonate, potassium, magnesium, and vitamin B, C, and/or D. Although PIMs have
been identified, changes to an effective, safer alternative treatment option are not being made to
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patients’ medication regimens and treatment plans. Therefore, in order to safely and
appropriately manage geriatric patients with polypharmacy and MCC, evidence-based practices
indicate that PIMs should be identified and safer alternative treatment options should be
recommended if the risks outweigh the benefits (Health in Aging, 2015).
Organizational Readiness for Change
The Practice Improvement Capacity Rating Scale (Appendix A) is an instrument for
identifying and assessing an organization’s readiness to change and to conduct quality
improvement (QI) activity (Robert Wood Johnson Foundation, 2014). The instrument scores an
organization or practice with one of the three following colors: red meaning the practice is not
ready for QI measures, yellow that the practice has limited capacity for change but may in the
future, and green for the practice being ready and capable for immediate QI implementation
(Robert Wood Johnson Foundation, 2014). When utilizing this instrument, the first step is to
determine whom to interview at the chosen organization. Based on the responses from the
interview, each question is scored based on the criterion and weighted on a scale of 1 to 3 with 1
being of lowest importance and 3 being of highest importance (Robert Wood Johnson
Foundation, 2014). All criteria with a weight of 3 is considered a “must-pass” area and must
receive a green level in order to have a final score in green (Robert Wood Johnson Foundation,
2014). As the only patient care provider and owner of the clinic, the physician was interviewed.
Based on his responses, the clinic received an overall score of 250, which was determined by
multiplying the scored questions by the weighted criterion and adding each category to equal the
final score. The final score of 255 was at the green level according to the scale indicating that the
clinic was ready and capable for immediate QI implementation (Robert Wood Johnson
Foundation, 2014).

BEERS CRITERIA IMPLEMENTATION

17

Project Identification and Focus
The purpose of this QI project was to implement the AGS’ Beers Criteria to promote
medication safety by the identification of potentially inappropriate medications and the
prevention of medication-related complications among the geriatric population 65 years and
older with MCC. By implementing the Beers Criteria into the medication reconciliation process,
the primary objective was to increase the number of charts for geriatric patients 65 years and
older being reviewed for potentially inappropriate medications from 0% to 80% over a 6-week
period. The second objective was to increase the number of PIMs that are changed to alternative
medication or treatment options based on the recommendations of the Beers Criteria from 0% to
25% over a 6-week period.
Summary and Strength of the Evidence
A literature review was conducted on the topic of the implementation of the AGS’ Beers
Criteria, polypharmacy, and the identification of PIMs. The literature reviewed was focused on
the elderly population 65 years and older in various settings and subpopulations to include acute,
hospitalized patients and outpatient, community-dwelling patients. The overall strength of the
articles and the AGS’ Beers Criteria are acceptable and reliable sources to be used as evidence in
support of this QI project.
Prevalence of PIMS
Narayan and Nishtala (2015) conducted a cross-sectional analysis with 559,625
participants to examine the prevalence of PIMs among the elderly population aged 65 and older
in the country of New Zealand. Based on this study, PIMs are prevalent in this the geriatric
population with approximately 40% of patients being prescribed at least one PIM (Narayan &
Nishtala, 2015). The results of this study identified the highest exposure of PIMs among 65 to 74
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year old patients and the most commonly identified PIMs to be nonsteroidal anti-inflammatory
drugs (NSAIDs), benzodiazepines, and amitriptyline (Narayan & Nishtala, 2015). Another study
conducted by Skaar & O’Connor (2017) concluded with similar results that approximately 57%
of dental patients aged 65 years and older were prescribed at least one PIM. It was identified that
the most prevalent PIMs were proton pump inhibitors, NSAIDS, and benzodiazepines with
common adverse effects of xerostomia, sedation, gastrointestinal bleeding, orthostatic
hypotension, and falls (Skaar & O’Connor, 2017). Women and patients of lower socioeconomic
status were also associated with an increased number of PIM prescriptions (Skaar & O’Connor,
2017). A retrospective study with 523,811 elderly subjects age 65 years and older was conducted
by Nam, Han, Kim Bae, and Lee (2016) in South Korea. This study identified that common
predictors of PIM prescriptions included the age of 65 years and older, the female sex,
polypharmacy, MCC, and the severity of these chronic conditions (Nam et al., 2016). Nam et al.
(2016) also identified a potential cause for the high prevalence of PIM prescription to be “doctorshopping” from one physician to another without a system or process to inhibit such patient
activity. Therefore, based on these studies, there is an issue with the prevalence of PIMs among
the geriatric population with increased risk based on gender, socioeconomic status, MCC,
polypharmacy, and poor health conditions.
AGS’ Beers Criteria vs. STOPP/START
Boland et al. (2016) conducted a randomized control trial with 20 patients aged 65 years
and older at a teaching hospital in Ireland to compare the Beers criteria and Screening tool of
Older Persons’ Prescriptions/Screening Tool to Alert to Right Treatment (STOPP/START) in
terms of the tools’ impact on the incidence and identification of PIMs among older adults. The
findings indicated the Beers Criteria to be highly effective in identifying PIMs and reducing
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polypharmacy among older adults; however, the STOPP/START showed to be slightly more
superior in identifying PIMs in this population (Boland et al., 2016). A similar study was
conducted in China to compare the Beers Criteria with the STOPP criteria in assessing and
identifying PIMs among older adults. This retrospective cross-sectional study with 6,337
participants showed the Beers Criteria had a higher detection rate of PIMs and was more
sensitive in assessing PIM use (Li et al., 2017). Despite the conflicting results of these two
studies, both studies show that the Beers Criteria is an effective and reliable tool for the
screening and identifying of PIMs in the geriatric population 65 years and older.
Zeenny et al. (2017) conducted a cross-sectional observation study with a secondary
objective to compare PIM prevalence rates as per the Beers Criteria 2003 and 2012 version. In
this study consisting of 248 patients aged 65 years and older, a high prevalence of PIMs was
identified utilizing both the 2003 and 2012 version of the Beers Criteria (Zeenny et al., 2017).
However, the study results identified the Beers Criteria of 2012 to be the more effective version
of this tool in identifying PIMs due to its significantly higher percentage of PIM identification
among the sample in comparison to the 2003 version; 45.2% with the Beers Criteria 2012 versus
27% with the 2003 (Zeenny et al., 2017). Unlike the 2003 version, the effectiveness of the Beers
Criteria of 2012 in PIM identification is associated with its classification of PIMs in the
following three categories: 1) PIMs and the classes of medication to avoid in the older adult
population, 2) PIMs and medication classes to avoid in older adults with certain disease and
syndromes that the medication may exacerbation, and 3) medications to be used with caution in
the older adult population (Alhmoud, Khalifa, & Bahi, 2015; Zeenny et al., 2017).
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Benefits and Limitations of the Beers Criteria
Although there are no national guidelines requiring the utilization and implementation of
the AGS’ Beers Criteria in the treatment and management of geriatric patients 65 years and
older, the evidence supports the effectiveness of the Beers Criteria in identifying PIMs and the
need to implement it due to the prevalence of PIM use and PIM predictors in the geriatric
population. The PIMs listed on the Beers Criteria are associated with more risks and adverse
health outcomes such as increased hospitalization, mortality, gastrointestinal bleeding, falls,
fractures, and other ADEs (Narayan & Nishtala, 2015).
Although the Beers Criteria is a valuable reference tool for the promotion of medication
safety, this tool does have limitations. One limitation is that the Beers Criteria is a reference tool
to identify PIMS and to prevent ADEs in the elderly population that does not take into
consideration the patient’s health status and unique circumstances. Therefore, this tool should not
replace the healthcare provider’s clinical judgment. According to Alhmoud et al. (2015), another
limitation is the Beers Criteria’s inclusion of medications that are not considered to be
contraindicated in the geriatric population by other updated and evidence-based drug formularies
such as the British National Formulary. Despite these limitations, the Beers Criteria remains a
valuable tool in the identification of PIMs in order to prevent health complications and ADEs
among the vulnerable population of elderly patients 65 years and older with MCC.
Methods
Project Intervention
In order to properly implement the Beers Criteria and identify PIMs in the geriatric
population aged 65 years and older at this nephrology specialty clinic, the physician and office
staff were educated regarding the QI measure and their designated role in the implementation
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process. Before the intervention plan was initiated, a 30-minute education session was scheduled
during the clinic’s lunch hour when all staff members were gathered in one location. During this
education session, the staff was educated via a PowerPoint presentation regarding the prevalence
and identification of PIMs in the elderly population 65 years and older with additional risk
factors such as MCC and polypharmacy increasing this population’s risk of experiencing ADEs.
Hence, the staff was made aware of the need to implement the AGS’ Beers Criteria in order to
promote patient safety and improve quality of care. The Beers Criteria and its purpose as a
reference tool to guide a healthcare provider’s treatment plan to promote medication safety was
explained. Although the physician was not required to change a medication that was identified as
a PIM by the Beers Criteria if deemed unnecessary, the physician was prompted to review all
identified PIMs and validate the need to continue or change. The staff was also instructed and
trained to fulfill their designated role in the implementation process. Education materials were
provided to each staff member, which included a flow sheet of the intervention process
(Appendix B), a pocket guide of the Beers Criteria, and a copy of the PIM Identification
checklist (Appendix C). In addition to providing the Beers Criteria pocket guide to each staff
members, the DNP student placed a copy of the pocket guide in each of the patient rooms in
order for it to be readily accessible to both the MA and physician. See Appendix D for additional
details regarding the intervention process and the estimated costs of education materials.
The intervention process began with the patient attending their regularly scheduled
appointment. At the start of each patient’s appointment, the front desk receptionist checked-in
the patient and determined if the patient is eligible to participate in the QI project. The eligibility
criterion was the geriatric patient 65 years or older with all current medications and herbal
supplements. The clinic requires that all patients bring all medications and supplements that they
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are currently consuming. If the patient met this criterion, the front desk receptionist placed the
PIM Identification checklist with the patient’s name and date of birth in the patient chart to be
filled out by the medical assistant and physician. The PIM Identification checklist was designed
by the DNP student and utilized as a documentation tool to note the medical assistant’s
completion of tasks and to document the physician’s clinical judgment regarding a patient’s
medication regimen.
Once the patient was checked-in, the medical assistant proceeded with the normal process
of weighing, obtaining vital signs, and documenting the patient’s current medications and
supplements in the chart. Documentation of all medications included the medication name, dose,
frequency, and route that the medication was being taken. After the patient’s medications were
documented, the medical assistant compared the list of the patient’s medications with the Beers
Criteria. All medications that met the Beers criteria were noted identifying these medications as
PIMs that needed to be reviewed by the physician. Once the MA completed these tasks, he
placed a check next to each of the tasks that were completed documenting on the checklist that
the intervention process was followed as planned.
After entering the patient room, the physician received the patient’s chart with the
checklist and the patient’s medication documented inside the chart. Based on the patient’s
medical history, health status, and the awareness of any PIMs that the patient was consuming, the
physician evaluated the patient’s treatment plan and determined whether to continue with the
current medication regimen or recommend an alternative treatment option. In addition to the
physician’s SOAP note documented in the chart, his decision regarding treatment was
documented on the checklist by circling one of the following options: “Continue with same
treatment” or “Recommend alternative treatment.” If the physician chose to continue with the
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same treatment plan and medication regimen, the checklist provided a section for the physician
to indicate the rationale for his decision or why the patient will continue with the same therapy.
Similarly, if the physician changed medications or chose an alternative treatment option, the
physician documented these changes and his rationale for the change in the patient’s treatment
plan. All changes in the patient’s treatment plan or medication regimen were documented on
either the patient’s chart or the checklist documented on the patient’s chart. It was essential to
document these changes in the patient’s chart for the physician’s use to recall the change that
was made and for the office’s use to provide refills as needed. Later, for data collection and
analysis, the DNP student noted any changes in treatment that were made at the time of the visit
and documented these changes onto the checklist for data collection. For the physician’s
convenience, the checklist included rationales that simply needed to be circled to document the
physician’s rationale for choosing one of the above-mentioned options. If the rationales on the
checklist did not pertain to his decision, the physician manually documented his decision and
wrote out his rationale on the “Other” option.
At the end of the patient’s scheduled appointment, the front desk receptionist received the
patient’s chart and checked-out the patient. The PIM identification checklist was removed from
the patient’s chart and placed in a designated folder for data collection and analysis. At the end
of each week, the DNP student collected the checklists and formulated a census of all eligible
patients scheduled for an appointment at the clinic during the week. Utilizing the patient
identification on the checklists, the DNP student pulled all the charts of each eligible patient who
participated in the QI measure and had a checklist completed regarding their treatment plan.
Once the charts were pulled, the census was used to determine the percentage of patients who
were scheduled, met the eligibility criteria, and were provided a checklist to review their
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medication list with the Beers Criteria. In addition to determining the percentage of patients’
medication regimens reviewed with the Beers Criteria, the checklist was utilized to evaluate the
number of PIMs that are changed to an alternative treatment based on the Beers Criteria
recommendations. The DNP student conducted a weekly review of the patient’s charts and PIM
Identification checklist to assess the patient’s medications, chronic conditions, and notation of
PIMs. For each PIM that was identified, the DNP student assessed if the physician chose to
maintain or alter the patient’s treatment plan. See Appendix E for data collection table.
In order to confirm that the QI measure was progressing as planned and sustainable, a 30minute staff meeting was scheduled at the halfway point of the implementation process to review
progress, answer questions, and improve processes of the project as needed. The staff meeting
was held during the office’s lunch hour to ensure that all staff members are present. During this
meeting, the DNP student presented the results gathered since the start of implementation,
suggested methods to improve the implementation process, and addressed any questions or
concerns that the staff had. During the implementation process if the DNP student identified an
issue with the QI project or the implementation process, the DNP student addressed the issue by
reminding the staff member regarding their role in the process and be willing to schedule
additional staff meetings as needed to address any issues or concerns. The last staff meeting was
held at the conclusion of the QI measure when the DNP presented the final results of the project
and thanked the staff for their endeavor in improving patient care.
Organizational Barriers and Facilitators
This specialty clinic possesses numerous strengths that facilitated the successful
completion and sustainability of this quality improvement measure. The physician recognized the
issue of PIMs in the geriatric population, acknowledged the relevancy of this QI measure in his
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practice, and was willing to participate in the project intervention. The clinic is a small practice
with only one physician and three office personnel that collaborate with one another to
effectively operate the clinic and to provide safe, quality care to patients. In addition to being a
small practice, trust is apparent in the strong relationship between each of the members of the
healthcare team at this clinic, which promotes collaboration and improves overall patient care.
The office staff is well-trained in their individual roles and has a strong work ethic that motivates
each member to accomplish their assigned tasks. Due to the healthcare team’s collaboration, the
practice operates efficiently with short wait times for patients and lessened burden on the
physician to micromanage his support staff. The physician is adamant regarding scheduling
ample appointment time for each patient and providing each patient the time and attention
needed to thoroughly assess and manage the complexity of these patients. Therefore, the clinic
also has a strong and positive reputation in the community and among patients; there is a
facilitation of trust and rapport between the patients, families, physician, and support staff.
Although the physician does not speak the Spanish language, the office manager and
medical assistant are proficient in the language. The clinic is located in an area with a large
Hispanic population; and there is a large percentage of Hispanic patients seen at this practice.
The office staff’s proficiency in the Spanish language facilitates trust and builds rapport between
patients seen at the clinic who may speak English as a second language or are only Spanishspeaking. Lastly, this QI measure was easily implemented into the practice’ medication
reconciliation process and was also cost-effective with minimal expenses needed to fund the
intervention.
Despite these strengths, there were also weaknesses and barriers that hindered this QI
measure. There was a lack of awareness and familiarity regarding the Beers Criteria. The initial
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implementation of the Beers Criteria in the practice’s medication reconciliation process was a
change that required supervision, reminding, and short period of adjustment for this transition.
The practice has not transitioned to electronic health records (EHR) and still utilizes the paper
chart. In comparison to the EHR, paper charting is a time-consuming process of locating, sorting,
and organizing these patient charts that prolonged the implementation and data collection
process.
As a small practice, the healthcare team has strong relationships with one another and
effectively collaborates; however, this also presents an issue. With only one physician to provide
patient care and three support staff with differing roles to operate the office, the absence of one
member will short-staff the office. The physician is only available at the clinic in the afternoon;
therefore, patients can only be scheduled between 2:00 p.m and 5:00 p.m.
The staff’s proficiency in the Spanish language may facilitate communication with
Spanish-speaking patients; however, they are not professionally certified medical translators.
This may be an issue as the staff may be unable to translate the physician’s instructions to the
patient with complete accuracy.
As a specialty practice that cares for chronically ill patients with MCC, many of these
patients have been attending this practice and receiving care from the physician for several years.
Therefore, these patients have been stabilized and compliant with the same medication regimen
with no ADEs. The physician and patients were hesitant to alter a medication regimen that has
effectively and safely improved and stabilized a patient simply due the Beers Criteria identifying
a PIM in the patient’s regimen. In addition to the hesitancy to alter an effective medication
regimen, the physician is a nephrologist that operates a specialty practice for treating and
managing renal disorders. The physician was reluctant and uncomfortable with discontinuing a
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medication prescribed by another physician and altering the treatment for a condition that is not
within his specialty. Other potential issues of switching to a newer or safer alternative treatment
option included patient refusal, the cost of purchasing a new medication, insurance coverage for
the medication, availability of the medication, and the effectiveness of this alternative option.
Ethical Considerations
During the implementation of this QI measure, it was essential to identify and address
any and all ethical concerns. The primary ethical consideration of this QI measure was patient
confidentiality. The intervention process required that the patient’s name and date of birth be
written on the checklist in order for the DNP student to identify the patient and pull the
appropriate chart to evaluate the project outcomes. In order to maintain patient confidentiality, a
confidentiality form was signed by the physician and the DNP student granting access to patient
information and charts. Also, all material containing patient information was only accessible to
the office staff and those granted permission by the physician via the confidentiality form.
During the intervention process, the folder containing the checklist was kept by the front desk
reception during office hours and stored in the chart room that was locked for closing hours. All
checklists with the patients’ personal information were properly disposed of in the practice’s
paper shredder at the conclusion of the QI measure. In addition to the confidentiality form, the
physician also wrote and signed a letter of support allowing the DNP student to utilize the
facility as a site for this QI measure (see Appendix F).
In addition to patient confidentiality, the patient’s socioeconomic status was another
ethical concern taken into consideration. For this QI measure, an objective was to promote safety
by altering PIMs for a safer alternative treatment option. Although an alteration of treatment may
promote safety, it may also raise financial concerns for patients of low socioeconomic status.
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Therefore, when evaluating the patient’s treatment plan, the physician took into consideration the
patient’s safety, current health condition, socioeconomic status, and insurance coverage. If the
patient was unable to access the alternative treatment option due to cost, lack of insurance
coverage, or unavailability of medication, the physician often had to continue with the same
treatment plan if the patient was content and not experiencing ADEs. Besides cost, another
ethical consideration was the effectiveness of alternative treatment. If the patient was on a stable
treatment plan or alternative treatment was not as effective as the PIM, the physician often
deemed that the benefits outweighed the risk and chose to continue with the same treatment plan.
The alternative treatment option was only recommended if the treatment was effective and
benefits outweighed the risk for the patient’s health and safety.
Budget
Unfortunately, there are no national guidelines requiring the implementation of the Beers
Criteria in the treatment and management of geriatric patients. The physician and his practice
were unable to charge and receive reimbursement for this intervention. Therefore, there was no
financial incentive for physician and the office staff’s participation in this QI measure. There
were minimal costs associated with the implementation of this QI measurement. The expenses
for this project included the teaching material (4 flow sheets, 6 Beers Criteria pocket guides, 4
PIM Identification checklists), 120 PIM Identification checklist for the intervention process, the
confidentiality folder, and meals for the education sessions and staff meetings. The costs for the
purchase and printing of materials necessary for this intervention are as follows:
•

$50 for each meal provided at the education session and staff meetings
o Three scheduled meetings at the start, mid-way point, and conclusion of this
project.
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Cost of purchasing and printing material for intervention
o $2 for the Confidentiality folder
o $10 for the paper and cost of printing material

•

Total cost equaled $162.00

In comparison to the cost of hospitalization or treatment of other ADEs, this project was a
cost-effective intervention that served as a QI measure to promote patient health outcomes and
prevent ADEs.
Results
A total of 112 eligible patients aged 65 years and older with all current medications and a
scheduled appointment at the time of the intervention were included in this QI measure. Patients
who failed to attend their scheduled appointment or bring all current medications to their
appointment were excluded from this intervention. Among the 112 participants, the average age
was 75.3 years. The majority of the participants seen at this clinic were of the female gender and
non-Hispanic African-American patients. The most common type of insurance seen at this
practice was Medicare followed by private insurance companies. Polypharmacy was a common
factor among the participants; the average number of prescribed medications was 7 medications.
The mean number of MCC was 5.19 chronic conditions. All (100%) of the participants were
diagnosed with at least one of the following chronic conditions: hypertension, diabetes mellitus
type 2, and chronic kidney disease. Of these patients, 79.61% (82/103) were diagnosed with
more than one of these conditions. The demographic results are presented in Table 1.
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Table 1. Sample Characteristics
Characteristics
Age, mean
Age, range
Sex, n (%)
Male
Female
Race, n (%)
White, non-Hispanic
African-American, non-Hispanic
Hispanic
Insurance, n (%)
Medicare
Dual Eligible (Medicare/Medicaid)
Private Insurance
Aetna
Humana
BCBS
Multiple Chronic Conditions, mean
Multiple Chronic Conditions, range
Number of Medications/Polypharmacy,
mean
Number of Medications/Polypharmacy,
range

75.3
65-90
37.5%
62.5%
13.39%
52.68%
34.95%
58.25%
4.85%
11.65%
6.78%
20.39%
5.19
2-9
7
2-20

This QI project had two objectives for which data was collected, analyzed, and evaluated
for separately. The first objective was to increase the number of eligible patients aged 65 and
above having their medication list reviewed with the Beers Criteria at each office visit from 0%
to 80%. The PIM Identification checklist (Appendix C) was utilized by the medical assistant and
physician as a “trigger” to review the medication list with the Beers Criteria and recommend
alternative treatment as needed. Of the 112 patients eligible to participate in this QI measure, 103
of these patients had their medication list reviewed by the Beers Criteria during their scheduled
appointment. This is a 91.3% (103/112) increase from the baseline of 0%, which exceeds the
target goal of 80%. PIMs were identified and noted in 57.2% (59/103) of the patients charts that
were reviewed with the Beers Criteria. In this PIM group (patients with identified PIMs using the
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Beers Criteria), 79.66% (47/59) had at least one identified PIM that the patient was currently
consuming. Another 20.34% of these PIM group patients had two or more PIMs identified in
their medication list. The prevalence of PIMs increased with the female gender, the number of
chronic conditions, and increasing age. The most common types of PIMs identified using the
Beers Criteria were benzodiazepines (15.25%), first-generation antihistamines (11.86%),
sulfonylureas (11.86%), and nonsteroidal anti-inflammatory drugs (NSAIDs) (11.86%). Table 2
lists the top 10 categories of PIMs identified by reviewing the patients’ medication lists using the
Beers Criteria.
The second objective was to increase the number of PIMs changed to an alternative
medication or treatment option from 0% to 25% based on the Beers Criteria recommendations.
Of the 59 patients with PIMs identified in their medication list, only 7 of these patients had the
identified PIM(s) changed to an alternative medication or treatment option. Although it does not
meet the goal of the second objective, it is an 11.8% increase from the baseline of 0%. The most
common rationales for not changing the PIM and utilizing an alternative treatment option were
patient refusal (25%), need for consultation with the physician who prescribed the PIM
(15.83%), and the effectiveness of the current medication regimen without ADEs (53.85%).
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Table 2. Beers Criteria Implementation and Identification of PIMs
Medication List reviewed with Beers
Criteria
Medication List with Identified PIMs
Number of Identified PIMs
At least one PIM
Two or more PIMs
PIMs among Gender
Female
Male
Top 10 Most Common PIMs
Benzodiazepines
Hormone Replacement
Amitriptyline
Amiodarone
Alpha-2 Agonist
NSAIDs
Antidepressants
Muscle Relaxants
1st Generation Antihistamines
Sulfonylureas
Vasodilators

n (%)
91.3%
57.2%
79.66%
20.34%
54.69%
48.98%
15.25%
10.17%
8.47%
3.39%
8.47%
11.86%
3.39%
8.47%
11.86%
11.86%
3.39%

Throughout the duration of this QI measure, all data was collected for the purpose of
analyzation and evaluation via a data collection spreadsheet on Microsoft Excel (Appendix E).
Each of the objectives were evaluated by calculating and comparing the percentage changes from
pre- and post-intervention. The mean and/or range of a variable were calculated using Microsoft
Excel.
Discussion
The QI intervention aimed to promote medication safety and to prevent medicationrelated complications by implementing the Beers Criteria into the medication reconciliation
process to identify PIMs in geriatric patients aged 65 years and older. The Beers Criteria was not
utilized prior to this intervention. A total of 103 patients (91.3%) had their medication list
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reviewed with Beers Criteria, which is a significant increase that surpassed the goal of the first
objective. At the start of the intervention, the practice struggled with the change of implementing
a new step into their medication reconciliation process and failed to review the medication list of
five eligible patients. Once the staff was able to adjust to the change, there was improvement in
placing the PIM Checklist in patient charts to trigger the medical assistant to utilize the Beers
Criteria and the physician to review the patient’s treatment plan. According to the front desk
receptionist, the failure to review an eligible patient’s medication list with the Beers Criteria was
her fault for not placing the PIM Checklist in the patient’s chart. She stated this failure to fulfill
her task was due to patients that were worked into the evening schedule that morning and she
was unable to prepare the patients’ charts with the PIM checklist the evening before, which is her
usual process of patient chart preparation. Recommendations for addressing this concern would
be to maintain the current process, but also have the PIM checklist readily available for last
minute schedule additions. See Figure 1 for the weekly progression of this QI intervention.

Intervention Progress over 6-Week Period
30
25
20
15
10
5
0

Week 1

Week 2

Week 3

Week 4

Week 5

Week 6

Total Number of Eligible Patients Seen at Clinic

Med List reviewed with Beers Criteria
Med List NOT Reviewed with Beers Criteria

Figure 1. Intervention Progress over 6-Week Period. This figure illustrates the weekly census of
eligible patients and the weekly progression of implementing the AGS’ Beers Criteria to review
the patients’ medication lists for PIMs.
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The prevalence of PIMs was relatively high; 57.2% of patients had at least one PIM
identified in their medication list. This prevalence increased with the increasing number of
chronic conditions, the increasing age of a patient, and among the female gender. These findings
are consistent with previous studies conducted by Narayan & Nishtala (2015), Skaar &
O’Connor (2017), and Nam et al. (2016). The study conducted by Narayan & Nishtala (2015)
identified the most common types of PIMs to be NSAIDs, benzodiazepines, and amitriptyline.
Similarly, for this QI intervention, the top four most commonly identified PIMs were
benzodiazepines, NSAIDs, first generation antihistamines, and sulfonylureas. As an individual
ages, the older adult experiences numerous age-related physical changes leading to the diagnosis
of more chronic medical conditions and the need for more medication to manage these
conditions. Therefore, it is essential for healthcare providers to seriously consider medication
safety, drug-disease interactions, and non-drug treatment options for this vulnerable population
before prescribing additional medications.
The use of alternative medication or treatment options were relatively low in comparison
to the prevalence of PIMs. The most common rationale for not changing the PIM to an
alternative treatment was the effectiveness of the current medication regimen without ADEs and
the benefits of the regimen outweighing the risks. Due to the complexity and chronicity of these
patients’ conditions, the physician was limited in the selection of treatment and unable to alter
the patient’s medication regimen. In such cases, the physician would not change the PIM that has
stabilized and effectively managed the patient’s conditions for years. Increasing age was another
factor that contributed to the lack of alternative treatment use. The older the patient’s age, the
more reluctant the patient became to alter a medication regimen that was effective in managing
the chronic conditions. Therefore, patient refusal was another common reason for not altering a
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medication regimen. There were various reasons for patient refusal including financial concerns,
lack of insurance coverage, familiarity with the current regimen, or simply due to the years of
effective management with their current treatment plan. The physician is a nephrologist that
specializes in the treatment and management of renal disorders and other chronic conditions
associated with renal disease such as hypertension, diabetes mellitus, and hyperlipidemia. The
physician was reluctant to discontinue a medication prescribed by another physician and treat a
condition that was not within his specialty. Instead, the physician chose to consult the physician
who prescribed the PIM or have the patient discuss with that physician regarding the PIM and
other alternative treatment options.
Limitations
Several limitations should be noted in this QI intervention. First, the health conditions of
the patients that participated in this intervention. Due to the complex nature of these patients’
health conditions, treatment and management of their various conditions were often intense and
individualized for each patient. As a result, the physician was unable to change to the PIM to an
alternative medication for several patients because the PIM was vital in stabilizing the patient’s
chronic condition and optimizing health outcomes. Second, the clinic was a specialty practice.
Although the physician did collaborate and consult with the physicians who prescribed the PIM,
this intervention may have been more effective in a primary care setting that functions as the
“gatekeeper” of the various specialties seen by a patient.
Recommendations
Based on the results of this QI measure, it is recommended to implement the intervention
of reviewing the medication lists of all patients aged 65 years and older with the Beers Criteria in
a primary care setting. Although an effective intervention when implemented in a specialty
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practice, the physician deemed this intervention would be more effective in a primary care
setting due to his reluctance to discontinue medication for a condition that was not within his
specialty. The physician did consult with the prescribing physician regarding alternative
treatment or advised the patient to discuss alternative treatment options with the physician.
However, the role of a primary care provider (PCP) is to provide treatment and preventive care
across a life span. If the Beers Criteria were implemented in a primary care setting, a PCP could
prevent the use of PIMs before reaching the age of 65 years and older. In situations where a PIM
was identified for a geriatric patient, the PCP could alter the PIM as appropriate or function as
the gatekeeper promoting collaboration with the various physicians and specialties caring for the
patient in order to promote wellness and prevent complications.
In terms of continuing this project at the current practice, it was a relatively easy and
simple intervention that added one additional step to the practice’s already-existing medication
reconciliation process. The additional step was to review the medication list documented in the
patient’s chart with the Beers Criteria and notate any PIMs that were identified. Due to this
simplicity and the easy adaptability into the medication reconciliation process, the intervention
should be easily sustainable at this practice. Furthermore, after this 6-week period, the
intervention has become embedded into the practice’s culture. The PIM Identification Checklist
served as a trigger to remind the medical assistant of the process until it became a part of the
culture. However, it is recommended that the practice format the PIM Checklist according to
their needs, such as removing the requirement for physician rationale that was pertinent to only
this project, and continue to utilize the checklist for the sustainability of this intervention.
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Implications for Practice
The purpose of the Beers Criteria is to identify potentially inappropriate medications that
present a higher risk for ADEs and other medication-related complications when used in the
geriatric population. By increasing awareness of the Beers Criteria and implementing it into the
medication reconciliation process, healthcare providers are able to identify PIMs and consider
safer alternative medication or non-drug treatment options. These actions of identifying potential
harm and considering alternatives promote medication safety in this vulnerable population.
Alteration of treatment for any identified PIM is not required; however, this intervention
promotes patient safety by identifying the potential hazards and reminding the healthcare
provider to carefully consider the risks and benefits of treatment for the patient. Overall, this
project was implemented as quality improvement intervention to increase the quality of patient
care, promote patient safety through safe medication use, and optimize patient outcomes by
preventing ADEs.
In addition to promoting overall patient safety and optimizing health outcomes, this
project promotes inter-professional collaboration and facilitates communication between the
patient and physician. The identification of a PIM prompted the physician to discuss treatment
options and compare the risk versus the benefits of the PIM with the patient. If the patient was
willing to consider alternative treatment not within the physician’s specialty, he would advise the
patient to discuss these options with the physician who prescribed the PIM or he would
personally consult with that physician regarding the PIM. Although a simple intervention
implemented to promote safety and improve health outcomes, this project demonstrated the
potential of improving communication and collaboration among PCPs, specialty practices,
pharmacists, dietitians, and other members of a healthcare team.
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A Doctorate of Nursing Practice (DNP) prepared nurse is trained to be leader who
possesses a wide array of knowledge in the sciences and translates this knowledge into practice
to improve patient care (American Association of Colleges of Nursing [AANC], 2006). At the
doctorate level, a nurse should possess the ability to assess an organization, identify issues within
a system, and facilitate change within an organization’s processes (AANC, 2006). According to
the AANC (2006), the facilitation of change should originate from the knowledge of diverse
sources and disciplines that is translated into practice in order to solve practice problems and
improve health outcomes. In addition to assessing for the need for change and facilitating
change, the DNP-prepared nurse should also be able to develop an intervention process,
implement the intervention, and evaluate the process through observation, data collection, and
analysis. The DNP-prepared nurse is also trained to possess leadership skills to establish and
facilitate collaboration among a healthcare team. It is essential for the DNP-prepared nurse to
possess this wide array of knowledge and these various skills sets in order to implement QI
measures within an organization and effectively promote change. For this project, the DNP
student had to demonstrate knowledge in the areas of physiological changes in the aging process,
pharmacologic safety in the geriatric population, and the evidenced-based practices utilizing
published clinical guidelines, in this case, the Beers Criteria. The AANC’s DNP essentials and
role were also exemplified by the DNP student when the problem was identified, an action plan
was developed, the intervention was implemented, and progress of the intervention was
evaluated via data collection and analysis. The project took coordination and collaboration
between various areas of clinical practice in order to have a successful implementation,
evaluation of results, and working to develop sustainability for the practice change. This is the
definition of the doctoral nursing practice.
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Project Intervention Flow Chart
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front desk

Physician
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patient care
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DNP student
will collect all
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of all eligible and
scheduled patients
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PIM Identification Checklist
PIM IDENTIFICATION CHECKLIST
Name: ______________________________ Age: ______y.o.
DOB: ____________ Ethnicity: __________ Gender: M / F
___ 1. List of patient’s current medications and supplements documented in
the patient’s chart.

PIM IDENTIFICATION CHECKLIST
Name: ______________________________ Age: ______y.o.
DOB: ____________ Ethnicity: __________ Gender: M / F
___ 1. List of patient’s current medications and supplements documented
in the patient’s chart.

___ 2. Patient’s medications compared AGS’ Beers Criteria

___ 2. Patient’s medications compared AGS’ Beers Criteria

___ 3. All PIMs have been highlighted for physician evaluation.

___ 3. All PIMs have been highlighted for physician evaluation.

___ 4. Physician’s treatment plan documented with rationale.
A. Continue with same treatment
a. Treatment effective; no ADEs and benefits outweigh risks
b. Consult with physician who prescribed PIM
c. Patient refuses alternative treatment
d. OTHER: _____________________________
B. Recommend alternative treatment
a. PIM identified; safe and effective alternative treatment
available
b. Patient experiencing ADE
c. OTHER: ______________________________

___ 4. Physician’s treatment plan documented with rationale.
A. Continue with same treatment
a. Treatment effective; no ADEs and benefits outweigh risks
b. Consult with physician who prescribed PIM
c. Patient refuses alternative treatment
d. OTHER: ______________________________
B. Recommend alternative treatment
a. PIM identified; safe and effective alternative treatment
available
b. Patient experiencing ADE
c. OTHER: _______________________________

ALTERNATIVE TREATMENT OPTION:

**Please place checklist in the folder located at the front desk. **

Patient meets criteria (65 years and older): Yes // No
Chronic diseases: HTN / DM2 / HLD / CKD / Other: _____________
Number of prescription medications: __________________________
Number of identified PIMs: ____ // Name: _____________________
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ALTERNATIVE TREATMENT OPTION:

**Please place checklist in the folder located at the front desk. **

Patient meets criteria (65 years and older): Yes // No
Chronic diseases: HTN / DM2 / HLD / CKD / Other: _____________
Number of prescription medications: __________________________
Number of identified PIMs: ____ // Name: _____________________
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Action Plan for Project Intervention
Table 1
Action Plan
Task
Preparation of material
for education session and
QI measure

Materials
Beers Criteria pocket
guide, intervention plan
flow sheet, checklist,
designated
confidentiality folder

Space
DNP student’s
home/Printing
store

Finance /
Budget
Cost of paper
and printing of
teaching
material for the
education
session
• 4 flow
sheets
• 6 Beers
Criteria
pocket
guides
• 4
checklists
for
meeting;
100
checklist
total for
the
project

Time Frame
WEEK 0
Complete one week
before initiation of QI
measure

Personnel
DNP student

BEERS CRITERIA IMPLEMENTATION
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4 hours for preparation
of all materials needed;
Complete one week
before initiation of QI
measure
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Obtain buy-in and input
of staff regarding QI
measure

N/A—inform staff of
the upcoming meeting

N/A—communication
with staff

Office

Office

No associated
cost

WEEK 0
Complete one week
before initiation of QI
measure
Verbally inform staff of
meeting; 1 min
WEEK 0
Complete one week
before initiation of QI
measure

DNP Student

DNP student
and staff
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Arrange an education
session/meeting to
introduce QI measure to
staff

Cost for
printing$10.00
No associated
cost

Communication with
staff regarding QI
project; 20 mins
Education
Session/Introduction of
QI measure to staff

Beers Criteria pocket
guide, intervention plan
flow sheet, checklist

Office’s break
room during the
staff’s lunch
hour

Meal ($50
each meal);
Cost of paper
and printing of
teaching
material for the
education
session
• 4 flow
sheets
• 6 Beers
Criteria

WEEK 0
Complete 3 days before
initiating QI measure
30-min education
session before initiating
QI project

All staff
members—MD,
MA, OM, and
front desk
receptionist
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pocket
guides
• 4
checklists
for
meeting;
100
checklist
total for
the
project
• Cost for
printing$10.00
Cost of
WEEK 0
printing the
Complete one day
checklist
before initiating QI
project; 1 min

Place copies of checklist
at the front desk for
patient check-in

Checklist

Lobby/Front
Desk

DNP student

Place copies of Beers
Criteria pocket guide in
patient exam room for
MA

Beers Criteria pocket
guide

Patient exam
room

Cost of
printing the
Beers Criteria
pocket guide

WEEK 0
Complete one day
before initiating QI
project; 1 min

DNP student

Place confidential folder
for checklist at front desk

Designated folder for
confidentiality of
checklists

Lobby/Front
Desk

Cost of folder
($2.00)

DNP student

Patient Intervention
Process

Sign-in sheet, patient
chart, PIM

Office

Employee
payment; cost

WEEK 0
Complete one day
before initiating QI
project; 1 min
WEEK 1-6

DNP student
and all staff
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of purchasing
and print of
materials—
checklist,
Beers Criteria
pocket guide,
folder

•
•
•
•
•
•

• Check-in patient

• Sign-in sheet,
patient chart, copy
of insurance

• Lobby/Front
Desk

• Placement of
checklist in chart

• Checklist

• Lobby/Front
Desk

• Call back to patient
room and obtain
patient’s vital signs

• Chart with labs and
SOAP note,
medical

• Hallway
and patient
exam room

• N/A—
already a
process
practiced
and funded
by the
clinic
• Cost of
paper and
printing of
checklist
• N/A—
process of
the clinic;

Week 1: Jan 29Feb 1
Week 2: Feb 5Feb 8
Week 3: Feb 1215
Week 4: Feb 1922
Week 5: Feb 26March 1
Week 6: March 4March 8

6-week period of the
intervention process
• At the start of
every appointment;
10 mins

• After determining
if patient meets
eligibility criteria,
checklist is placed
in chart; 1 min
• After receiving
patient chart; the
start of the patient

members—MD,
MA, OM, and
front desk
receptionist
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Identification checklist,
appointment book

• Front Desk
Receptionist

• Front Desk
Receptionist

• Medical
Assistant
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• SOAP note,
checklist, Beers
Criteria

• Patient
exam room

• Notation/Highlight all
PIMs that meet Beers
Criteria

• Beers Criteria,
checklist, SOAP
note with med list

• Patient
exam room

• Physician enters room;
assesses patient and
evaluate treatment plan
• Physician documents
treatment plan—to
continue or alter
therapy
• Patient check-out;
Patient chart given to
receptionist

• SOAP note,
checklist

• Patient
exam room

• SOAP note,
checklist

• Patient
exam room

• Cost for
checklist

• Patient chart with
SOAP note and
checklist inside

• Hallway/
Front Desk

• N/A

• Patient
exam room

care process; 10
mins
• At the beginning
of patient’s
appointment; 5
mins.
• During patient’s
appointment; 5
mins

• Medical
Assistant

• During patient’s
appointment; 1
min.

• Medical
Assistant

• During patient’s
appointment; 20
mins
• During patient’s
appointment; 5
mins

• Physician

• Conclusion of
patient’s

• Medical
Assistant,

• Medical
Assistant
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• Comparison of
patient’s meds with
Beers Criteria

MA paid
by
physician
• Cost of
paper to
print
checklist
• Cost of
paper and
printing of
Beers
Criteria
pocket
guide
• Cost of
paper to
print
checklist
and Beers
Criteria
• Cost for
checklist

• Documentation of
patient’s medication
and supplements

equipment—
stethoscope, BP
cuff, etc.
• SOAP note and
checklist

• Physician
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• Checklist, folder

• Front desk

• Formulate census of all
scheduled patients 65
years and older
• Collection of
checklists

• Appointment book

• Hallway
desk area

• Folder with
checklists

• Cost of
checklists

• Pulling charts for all
patients that received
checklist
• Data collection &
Analysis/Evaluation
o % of patients’
medication lists
that were
reviewed based
on the Beers
Criteria
recommendations
o % of treatment
plans that are
changed to a
safer and
effective

• Checklists to pull
charts

• Front desk
and
hallway
desk area
• Chart room
• Hallway
desk

• N/A

• Chart with SOAP
note, checklist
o Checklist
filled out—
MA initialed
indicating all
tasks
(mediation
documentation
and review of
this list with
Beers Criteria)
were
completed

• Cost of
checklist
and folder
• N/A

• N/A

Front Desk
Receptionist
• Front Desk
Receptionist

• Census formulated
each week; 30
mins
• Collection will
occur every week;
1 min.

• DNP student

• Charts will be
pulled each week;
20 mins
• Data collection and
analysis will occur
every week; 5 hrs

• DNP student

• DNP student
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• Checklist removed and
placed in folder

appointment; 5
mins
• 1 minute

• DNP student
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• Additional staff
meetings and
education sessions

o Physician’s
documentation
of his decision
regarding
patient’s
treatment—to
continue or
alter
o If treatment is
changed,
alternative
treatment
documented
on either or
both the
SOAP note or
checklist
• Results of the QI
measure

BEERS CRITERIA IMPLEMENTATION

alternative
treatment option
o PIMs, type of
PIM, MCC,
polypharmacy

• Office’s
break room

• Meal; costs
of any
paper to
print out
visual
diagrams
of the
results of
QI measure

• 30 min.
• DNP student;
meetings/education
all staff
session during the
members
staff’s lunch hour
including
o A meeting will
MD, MA,
be scheduled
OM, and
at the half-way
front desk
point (Week
receptionist
3) of the QI
project
o Additional
meetings may
be scheduled
if there are any
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Note (only if applicable)

BEERS CRITERIA IMPLEMENTATION

issues,
questions, or
concerns
o The last staff
meeting will
be scheduled
at the
conclusion of
this QI
measure
(Week 6)
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Data Collection Table

D.o.B.

Age

Race

Med List
Reviewed Total # of
PIMs
Total # of
Ethnicity Sex/Gender Diagnoses Insurance Date of Appt. with Beers Medications Identified? PIMs

Alternative If alt.
Meds Meds
If not
Names of Treatment treatment changed changed changed,
PIMs
Used?
used,
from… to… Rationale?
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Letter of Support

57

